Biomensio Launches 5M€ Funding Round with Springvest


The ability to quickly identify dozens of analytes at the point-of-need gives the Biomensio technology platform a strong competitive advantage that is being reinforced further by the testing needs created by the current pandemic. 

Springvest is organizing this funding round for Biomensio with the maximum size of the round being 5 million Euros.  You can participate in this round in Finland at:

More in Finnish here.